node1	node2	edge_score	
DB01109	SERPINA7	1.0	
DB01109	SELP	1.0	
DB01109	SERPINC1	1.0	
DB01109	FGF2	1.0	
DB01109	FGF19	1.0	
DB01109	PF4	1.0	
DB01109	HGF	1.0	
DB01109	F10	1.0	
DB01109	FGF4	1.0	
DB01109	FGFR2	1.0	
DB01109	FGFR4	1.0	
DB01109	FGF1	1.0	
DB01109	FGFR1	1.0	
FGFR4		1.0
FGF2		1.0
 Adenocarcinoma, ovarian, somatic, 167000 (3)	FGF2	1.0	
 Adenocarcinoma, ovarian, somatic, 167000 (3)	FGFR4	1.0	
Adenomas, multiple colorectal, 608456 (3)	FGF2	1.0	
Adenomas, multiple colorectal, 608456 (3)	FGFR4	1.0	
Astrocytoma	FGF2	1.0	
Astrocytoma	FGFR4	1.0	
Malignant tumor of urinary bladder	FGF2	1.0	
Malignant tumor of urinary bladder	FGFR4	1.0	
Breast-ovarian cancer, familial 1	FGF2	1.0	
Breast-ovarian cancer, familial 1	FGFR4	1.0	
Colon cancer	FGF2	1.0	
Colon cancer	FGFR4	1.0	
Thyroid cancer, nonmedullary, 4	FGF2	1.0	
Thyroid cancer, nonmedullary, 4	FGFR4	1.0	
Non-small cell lung carcinoma	FGF2	1.0	
Non-small cell lung carcinoma	FGFR4	1.0	
Renal cell carcinoma, nonpapillary	FGF2	1.0	
Renal cell carcinoma, nonpapillary	FGFR4	1.0	
Squamous cell carcinoma	FGF2	1.0	
Squamous cell carcinoma	FGFR4	1.0	
Chordoma	FGF2	1.0	
Chordoma	FGFR4	1.0	
Colorectal cancer 1	FGF2	1.0	
Colorectal cancer 1	FGFR4	1.0	
Coronary heart disease 7	FGF2	1.0	
Coronary heart disease 7	FGFR4	1.0	
Adenoid Cystic Carcinoma	FGF2	1.0	
Adenoid Cystic Carcinoma	FGFR4	1.0	
{Unipolar depression, susceptibility to}, 608516 (3)	FGF2	1.0	
{Unipolar depression, susceptibility to}, 608516 (3)	FGFR4	1.0	
Depressive Disorder	FGF2	1.0	
Depressive Disorder	FGFR4	1.0	
Diabetes Mellitus, Type 1	FGF2	1.0	
Diabetes Mellitus, Type 1	FGFR4	1.0	
Diabetes mellitus type 2	FGF2	1.0	
Diabetes mellitus type 2	FGFR4	1.0	
Glioblastoma	FGF2	1.0	
Glioblastoma	FGFR4	1.0	
Head and Neck Neoplasms	FGF2	1.0	
Head and Neck Neoplasms	FGFR4	1.0	
Symptomatic human immunodeficiency virus infection	FGF2	1.0	
Symptomatic human immunodeficiency virus infection	FGFR4	1.0	
Hypertension	FGF2	1.0	
Hypertension	FGFR4	1.0	
Pulmonary hypertension, neonatal, susceptibility to	FGF2	1.0	
Pulmonary hypertension, neonatal, susceptibility to	FGFR4	1.0	
Leukemia, Lymphocytic, Chronic, B-Cell	FGF2	1.0	
Leukemia, Lymphocytic, Chronic, B-Cell	FGFR4	1.0	
Chronic Lymphocytic Leukemia	FGF2	1.0	
Chronic Lymphocytic Leukemia	FGFR4	1.0	
Acute lymphoid leukemia	FGF2	1.0	
Acute lymphoid leukemia	FGFR4	1.0	
Acute myeloid leukemia	FGF2	1.0	
Acute myeloid leukemia	FGFR4	1.0	
Chronic myeloid leukemia	FGF2	1.0	
Chronic myeloid leukemia	FGFR4	1.0	
Liver Cirrhosis, Biliary	FGF2	1.0	
Liver Cirrhosis, Biliary	FGFR4	1.0	
Neoplasm of the liver	FGF2	1.0	
Neoplasm of the liver	FGFR4	1.0	
Lymphoma, Large B-Cell, Diffuse	FGF2	1.0	
Lymphoma, Large B-Cell, Diffuse	FGFR4	1.0	
{Gastric cancer risk after H. pylori infection}, 137215 (3)	FGF2	1.0	
{Gastric cancer risk after H. pylori infection}, 137215 (3)	FGFR4	1.0	
Animal Mammary Neoplasms	FGF2	1.0	
Animal Mammary Neoplasms	FGFR4	1.0	
Melanoma	FGF2	1.0	
Melanoma	FGFR4	1.0	
Meningioma	FGF2	1.0	
Meningioma	FGFR4	1.0	
Multiple Myeloma	FGF2	1.0	
Multiple Myeloma	FGFR4	1.0	
Myeloproliferative Disorders	FGF2	1.0	
Myeloproliferative Disorders	FGFR4	1.0	
Secondary hypertriglyceridemia	FGF2	1.0	
Secondary hypertriglyceridemia	FGFR4	1.0	
Obesity	FGF2	1.0	
Obesity	FGFR4	1.0	
Osteoarthritis	FGF2	1.0	
Osteoarthritis	FGFR4	1.0	
Pituitary adenoma	FGF2	1.0	
Pituitary adenoma	FGFR4	1.0	
Abnormality of the pituitary gland	FGF2	1.0	
Abnormality of the pituitary gland	FGFR4	1.0	
Pituitary Neoplasms	FGF2	1.0	
Pituitary Neoplasms	FGFR4	1.0	
Precancerous Conditions	FGF2	1.0	
Precancerous Conditions	FGFR4	1.0	
Prostatic Neoplasms	FGF2	1.0	
Prostatic Neoplasms	FGFR4	1.0	
Scleroderma	FGF2	1.0	
Scleroderma	FGFR4	1.0	
Thyroid Neoplasms	FGF2	1.0	
Thyroid Neoplasms	FGFR4	1.0	
B-cell lymphoma	FGF2	1.0	
B-cell lymphoma	FGFR4	1.0	
Severe combined immunodeficiency due to ADA deficiency	FGF2	1.0	
Severe combined immunodeficiency due to ADA deficiency	FGFR4	1.0	
Cutaneous malignant melanoma 3	FGF2	1.0	
Cutaneous malignant melanoma 3	FGFR4	1.0	
Adenocarcinoma of lung	FGF2	1.0	
Adenocarcinoma of lung	FGFR4	1.0	
Secondary malignant neoplasm of lung	FGF2	1.0	
Secondary malignant neoplasm of lung	FGFR4	1.0	
Tumor Progression	FGF2	1.0	
Tumor Progression	FGFR4	1.0	
Embryonal Carcinoma	FGF2	1.0	
Embryonal Carcinoma	FGFR4	1.0	
Pancreatic Carcinoma	FGF2	1.0	
Pancreatic Carcinoma	FGFR4	1.0	
Gastrointestinal stromal tumor	FGF2	1.0	
Gastrointestinal stromal tumor	FGFR4	1.0	
Malignant neoplasm of lung	FGF2	1.0	
Malignant neoplasm of lung	FGFR4	1.0	
Cancer of Head and Neck	FGF2	1.0	
Cancer of Head and Neck	FGFR4	1.0	
Adenocarcinoma Of Esophagus	FGF2	1.0	
Adenocarcinoma Of Esophagus	FGFR4	1.0	
Solid tumour	FGF2	1.0	
Solid tumour	FGFR4	1.0	
Anaplastic astrocytoma	FGF2	1.0	
Anaplastic astrocytoma	FGFR4	1.0	
Malignant neoplasm of pancreas	FGF2	1.0	
Malignant neoplasm of pancreas	FGFR4	1.0	
Malignant tumor of prostate	FGF2	1.0	
Malignant tumor of prostate	FGFR4	1.0	
Endometrial carcinoma	FGF2	1.0	
Endometrial carcinoma	FGFR4	1.0	
Thyroid carcinoma	FGF2	1.0	
Thyroid carcinoma	FGFR4	1.0	
Malignant Glioma	FGF2	1.0	
Malignant Glioma	FGFR4	1.0	
Osteosarcoma	FGF2	1.0	
Osteosarcoma	FGFR4	1.0	
Carcinogenesis	FGF2	1.0	
Carcinogenesis	FGFR4	1.0	
Leukemogenesis	FGF2	1.0	
Leukemogenesis	FGFR4	1.0	
Prostate carcinoma	FGF2	1.0	
Prostate carcinoma	FGFR4	1.0	
Ovarian epithelial cancer	FGF2	1.0	
Ovarian epithelial cancer	FGFR4	1.0	
Breast carcinoma	FGF2	1.0	
Breast carcinoma	FGFR4	1.0	
Lung cancer	FGF2	1.0	
Lung cancer	FGFR4	1.0	
Carcinoma of colon	FGF2	1.0	
Carcinoma of colon	FGFR4	1.0	
Stomach cancer	FGF2	1.0	
Stomach cancer	FGFR4	1.0	
Bladder carcinoma	FGF2	1.0	
Bladder carcinoma	FGFR4	1.0	
Neuroblastoma	FGF2	1.0	
Neuroblastoma	FGFR4	1.0	
Ovarian Neoplasms	FGF2	1.0	
Ovarian Neoplasms	FGFR4	1.0	
Ischemic stroke	FGF2	1.0	
Ischemic stroke	FGFR4	1.0	
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	FGF2	1.0	
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	FGFR4	1.0	
Squamous cell carcinoma of the head and neck	FGF2	1.0	
Squamous cell carcinoma of the head and neck	FGFR4	1.0	
Sarcoma, Ewing	FGF2	1.0	
Sarcoma, Ewing	FGFR4	1.0	
B Acute Lymphoblastic Leukemia with t(9;22)(q34;q11.2); BCR-ABL1	FGF2	1.0	
B Acute Lymphoblastic Leukemia with t(9;22)(q34;q11.2); BCR-ABL1	FGFR4	1.0	
Colorectal cancer	FGF2	1.0	
Colorectal cancer	FGFR4	1.0	
Benign Prostatic Hyperplasia	FGF2	1.0	
Benign Prostatic Hyperplasia	FGFR4	1.0	
Hepatocellular carcinoma	FGF2	1.0	
Hepatocellular carcinoma	FGFR4	1.0	
Secondary malignant neoplasm of pancreas	FGF2	1.0	
Secondary malignant neoplasm of pancreas	FGFR4	1.0	
Experimental Organism Basal Cell Carcinoma	FGF2	1.0	
Experimental Organism Basal Cell Carcinoma	FGFR4	1.0	
Oropharynx (excludes nasopharynx)	FGFR4	1.0	
Treacher Collins syndrome	FGFR4	1.0	
Cardiovascular morbidity	FGF2	1.0	
Cystic Kidney Diseases	FGF2	1.0	
Achondroplasia	FGF2	1.0	
Thrombosis of retinal vein	FGF2	1.0	
Breast cancer recurrent	FGFR4	1.0	
Familial X-linked hypophosphatemic vitamin D refractory rickets	FGF2	1.0	
Pituitary dependent hypercortisolism	FGFR4	1.0	
Intermittent claudication	FGF2	1.0	
Spinal cord compression	FGF2	1.0	
Arteriovenous hemangioma	FGF2	1.0	
Pleomorphic adenoma of salivary gland	FGF2	1.0	
Generalized osteoarthritis	FGFR4	1.0	
Adenoviral infections	FGFR4	1.0	
Osteomalacia	FGF2	1.0	
Peptic Ulcer Hemorrhage	FGF2	1.0	
Pregnancy in Diabetics	FGF2	1.0	
Prostatic Diseases	FGF2	1.0	
Corneal neovascularization	FGF2	1.0	
Primary malignant neoplasm of brain	FGF2	1.0	
Cholesteatoma	FGF2	1.0	
Tumor-Associated Vasculature	FGF2	1.0	
AIDS Dementia Complex	FGF2	1.0	
Tubulointerstitial nephritis	FGF2	1.0	
Somatotroph adenoma	FGFR4	1.0	
Oropharyngeal disorders	FGFR4	1.0	
Pituitary corticotropic cell adenoma	FGFR4	1.0	
Choroidal Neovascularization	FGF2	1.0	
Melanocytic nevus of skin	FGF2	1.0	
Squamous cell carcinoma of mouth	FGFR4	1.0	
Exostoses	FGF2	1.0	
Osteopetrosis autosomal recessive 4	FGFR4	1.0	
Acute Cerebrovascular Accidents	FGF2	1.0	
Prenatal Exposure Delayed Effects	FGF2	1.0	
Cleft palate with cleft lip	FGF2	1.0	
Leukemia, Large Granular Lymphocytic	FGF2	1.0	
Multiple endocrine neoplasia, type 4	FGF2	1.0	
Endometriosis of uterus	FGF2	1.0	
Photoreceptor degeneration	FGF2	1.0	
Oral Submucous Fibrosis	FGF2	1.0	
X-linked agammaglobulinemia	FGFR4	1.0	
Ovarian adenocarcinoma	FGF2	1.0	
Pancreatic intraepithelial neoplasia	FGFR4	1.0	
Diaphragmatic hernia	FGF2	1.0	
Angiogenic Switch	FGF2	1.0	
Psychoses, Substance-Induced	FGF2	1.0	
Proliferative diabetic retinopathy	FGF2	1.0	
Fibroadenoma of the breast	FGFR4	1.0	
Limb ischemia	FGF2	1.0	
Well Differentiated Pancreatic Endocrine Tumor	FGFR4	1.0	
Contractures involving the joints of the feet	FGF2	1.0	
Pathologic Neovascularization	FGF2	1.0	
Pleural Effusion, Malignant	FGF2	1.0	
Myeloid neoplasm with beta-type platelet-derived growth factor receptor gene rearrangement	FGF2	1.0	
Ichthyosis bullosa of Siemens	FGFR4	1.0	
Brain Infarction	FGF2	1.0	
Williams syndrome	FGFR4	1.0	
Leukemia, Myeloid, Chronic-Phase	FGFR4	1.0	
Benign melanocytic nevus	FGF2	1.0	
Rash and Dermatitis Adverse Event Associated with Chemoradiation	FGF2	1.0	
Multiple Endocrine Neoplasia Type 1	FGF2	1.0	
Gastrointestinal Diseases	FGF2	1.0	
Alveolar rhabdomyosarcoma	FGFR4	1.0	
Gliosis	FGF2	1.0	
Embryonal rhabdomyosarcoma	FGFR4	1.0	
Diabetic Angiopathies	FGF2	1.0	
Vestibular Schwannoma	FGF2	1.0	
Arteriovenous malformation	FGF2	1.0	
Prolactinoma, familial	FGF2	1.0	
Marijuana Abuse	FGF2	1.0	
Interstitial fibrosis	FGF2	1.0	
Melanoma, B16	FGF2	1.0	
Myelofibrosis	FGF2	1.0	
Endometrial adenocarcinoma	FGF2	1.0	
Middle Cerebral Artery Occlusion	FGF2	1.0	
Teratoma	FGF2	1.0	
Severe Myopia	FGF2	1.0	
Idiopathic thrombocytopenic purpura	FGF2	1.0	
Hypercalcemia, infantile, 2	FGFR4	1.0	
Intracranial Aneurysm	FGF2	1.0	
Gastric ulcer	FGF2	1.0	
Immediate hypersensitivity	FGFR4	1.0	
Cocaine-Related Disorders	FGF2	1.0	
Goiter, multinodular 1, with or without sertoli-leydig cell tumors	FGF2	1.0	
Primary Effusion Lymphoma	FGF2	1.0	
Peripheral T-Cell Lymphoma	FGFR4	1.0	
Pancytopenia	FGF2	1.0	
Thrombophilia	FGFR4	1.0	
Impotence	FGF2	1.0	
Intraepithelial Neoplasia	FGFR4	1.0	
Differentiated Thyroid Gland Carcinoma	FGF2	1.0	
Anaplastic Oligodendroglioma	FGF2	1.0	
Basal cell carcinoma	FGFR4	1.0	
Pleural effusion	FGF2	1.0	
Hyperplasia	FGF2	1.0	
Mycosis Fungoides	FGF2	1.0	
Monoclonal Gammopathy of Undetermined Significance	FGF2	1.0	
Neurodegeneration with brain iron accumulation	FGF2	1.0	
Chronic liver disease	FGFR4	1.0	
Arthropathy	FGF2	1.0	
Barrett Esophagus	FGF2	1.0	
Essential thrombocythemia	FGF2	1.0	
invasive cancer	FGF2	1.0	
{Aneurysm, familial abdominal 3} (2)	FGF2	1.0	
Peripheral Arterial Disease	FGF2	1.0	
Hemangioma	FGF2	1.0	
Malignant neoplasm of brain and nervous system	FGF2	1.0	
Primitive neuroectodermal tumor	FGFR4	1.0	
Adrenocortical carcinoma	FGF2	1.0	
VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding)	FGF2	1.0	
Irritable bowel syndrome with diarrhea	FGFR4	1.0	
Acquired Immunodeficiency Syndrome	FGF2	1.0	
Myeloproliferative disorder (2)	FGFR4	1.0	
Hematopoietic Neoplasms	FGF2	1.0	
Bronchial Hyperreactivity	FGFR4	1.0	
Nevus	FGF2	1.0	
Thyroid cancer, follicular	FGF2	1.0	
Keloid	FGF2	1.0	
Nephritis	FGF2	1.0	
Primary Myelofibrosis	FGF2	1.0	
Kaposi's sarcoma	FGF2	1.0	
Melanocytic nevus	FGF2	1.0	
Fibrosis	FGF2	1.0	
Well Differentiated Oligodendroglioma	FGF2	1.0	
Neoplasms, Second Primary	FGF2	1.0	
Fetal Membranes, Premature Rupture	FGF2	1.0	
Chorioamnionitis	FGF2	1.0	
Premature Obstetric Labor	FGF2	1.0	
Arthritis, Psoriatic	FGF2	1.0	
Intraocular melanoma	FGF2	1.0	
Maternal diabetes	FGF2	1.0	
Cervical intraepithelial neoplasia (Cervical dysplasia)	FGF2	1.0	
Endothelial dysfunction	FGF2	1.0	
Meningioma, benign, no ICD-O subtype	FGFR4	1.0	
Craniosynostoses	FGF2	1.0	
Skin cancer	FGFR4	1.0	
Chondrosarcoma	FGF2	1.0	
Hearing Loss, Mixed Conductive-Sensorineural	FGF2	1.0	
Neoplasm of the oral cavity	FGFR4	1.0	
Primary pulmonary hypertension	FGF2	1.0	
Anaplasia	FGF2	1.0	
Disease Progression	FGF2	1.0	
Nasal polyposis	FGF2	1.0	
Ovarian Diseases	FGFR4	1.0	
Gastritis	FGF2	1.0	
Dermal atrophy	FGF2	1.0	
Vitiligo	FGF2	1.0	
Fibrosarcoma	FGF2	1.0	
Recurrent bacterial infection	FGF2	1.0	
Adenoma of large intestine	FGF2	1.0	
Nephrotic syndrome, type 5, with or without ocular abnormalities	FGF2	1.0	
Anaplastic large cell lymphoma, ALK negative	FGFR4	1.0	
RETINAL DYSTROPHY WITH OR WITHOUT MACULAR STAPHYLOMA	FGF2	1.0	
Malignant mesothelioma	FGF2	1.0	
Gastrointestinal Neoplasms	FGFR4	1.0	
Ewing's sarcoma	FGF2	1.0	
Diabetic Retinopathy	FGF2	1.0	
Neoplasm Recurrence, Local	FGF2	1.0	
Choriocarcinoma	FGF2	1.0	
Cardiomegaly	FGF2	1.0	
polyps	FGFR4	1.0	
Gastric Adenocarcinoma	FGF2	1.0	
Retinal degeneration	FGF2	1.0	
Ischaemic cerebral infarction	FGF2	1.0	
Reperfusion Injury	FGF2	1.0	
Pulmonary arterial hypertension	FGF2	1.0	
Leiomyoma	FGF2	1.0	
Huntington's chorea	FGF2	1.0	
Recurrent tumor	FGF2	1.0	
Cancer Cell Growth	FGFR4	1.0	
Mood Disorders	FGF2	1.0	
Uterine leiomyoma	FGF2	1.0	
Metastatic melanoma	FGF2	1.0	
Idiopathic Pulmonary Fibrosis	FGF2	1.0	
Cleft Lip	FGF2	1.0	
Epiphyseal dysplasia, multiple, with myopia and conductive deafness	FGF2	1.0	
Preeclampsia/eclampsia 1	FGF2	1.0	
T-cell acute lymphoblastic leukemias	FGFR4	1.0	
Premature Birth	FGF2	1.0	
Diarrhea 8, secretory sodium, congenital	FGFR4	1.0	
Rhabdomyosarcoma alveolar	FGFR4	1.0	
Mesothelioma, malignant	FGF2	1.0	
Heart Diseases	FGF2	1.0	
Experimental Autoimmune Encephalomyelitis	FGF2	1.0	
Urothelial Carcinoma	FGF2	1.0	
Pulmonary fibrosis and/or bone marrow failure, telomere-related, 4	FGF2	1.0	
Malignant neoplasm of kidney	FGF2	1.0	
Unipolar Depression	FGF2	1.0	
Hodgkin Disease	FGF2	1.0	
Vascular Diseases	FGF2	1.0	
Hepatic fibrosis	FGF2	1.0	
Age-related macular degeneration 2	FGF2	1.0	
Retinopathy	FGF2	1.0	
Glioblastoma multiforme	FGFR4	1.0	
Neoplasm of the skin	FGFR4	1.0	
Tumor Angiogenesis	FGF2	1.0	
Papillary thyroid carcinoma	FGF2	1.0	
Hepatitis C, Chronic	FGF2	1.0	
Hyperglycemia	FGF2	1.0	
Triple Negative Breast Neoplasms	FGF2	1.0	
Urinary Bladder Neoplasms	FGF2	1.0	
Hepatocarcinogenesis	FGFR4	1.0	
Retinoblastoma	FGF2	1.0	
Acute myocardial ischemia	FGF2	1.0	
Major depressive disorder	FGF2	1.0	
Influenza	FGFR4	1.0	
Malignant neoplasm of endometrium	FGF2	1.0	
Uterine Corpus Cancer	FGF2	1.0	
Herpes Simplex Infections	FGF2	1.0	
Medulloblastoma	FGF2	1.0	
Xenograft Model	FGF2	1.0	
Non-Hodgkin lymphoma	FGF2	1.0	
Pancreatic Ductal Adenocarcinoma	FGFR4	1.0	
Cleft Palate	FGF2	1.0	
Esophageal carcinoma	FGF2	1.0	
Diabetic Nephropathies	FGF2	1.0	
Anemia	FGF2	1.0	
Small cell lung cancer	FGF2	1.0	
Scoliosis	FGF2	1.0	
Osteoporosis	FGF2	1.0	
Inflammation	FGF2	1.0	
Ischemia	FGF2	1.0	
Malignant tumor of esophagus	FGF2	1.0	
Brain neoplasm	FGF2	1.0	
Alcohol dependence	FGFR4	1.0	
Esophageal Neoplasms	FGF2	1.0	
Neurodegenerative Diseases	FGFR4	1.0	
Endometriosis	FGF2	1.0	
